- HealthTech
- Thursday, 16 Apr 2020
Real Time Announces Strategic Partnership with AMS Onsite to Advance Infection Prevention
Real-Time Medical Systems (Real Time), the Interventional Analytics solution in healthcare, announces a strategic partnership with AMS Onsite, a fast-growing infection control management practice. AMS Onsite will embed Real Time's Infection Risk Identification tools into the nursing facilities its serves in order to stay ahead of potential infectious disease outbreaks.
Real Time's industry-leading Interventional Analytics solution extracts live clinical data from the LTPAC EHR and identifies subtle changes in resident condition, pushing live alerts, to clinical teams in an effort to anticipate adverse situations before they occur. Following the emergence of COVID-19, Real Time launched its Infection Risk Identification tools to its 1000+ customers, for remote monitoring. The service identifies early warning signs of infectious diseases through a complex algorithm that includes increased temperature, high respiratory rate, cough and shortness of breath, to detect potential outbreaks in nursing facility communities.
AMS Onsite offers an all-inclusive infection control management program specifically developed for the LTPAC population. Providing certified Infection Preventionists, its team of clinical professionals deliver infection control leadership, support, training, and testing, including COVID-19, to meet infection control regulations and to keep residents safe.
"We are excited to be partnering with AMS Onsite," states Joan Neuscheler, Real Time Chief Executive Officer. "Utilizing Real Time's Infection Risk Identification tools, AMS Onsite's Infection Preventionists can immediately identify possible cases of infectious disease and work with the nursing facilities to prevent further outbreaks."
Patrick Britton-Harr, AMS Onsite Founder and Chief Executive Officer states, "We are very proud to be partnering with Real Time. With the emergence of COVID-19, our Infection Preventionists have also been under stressful moments to help our nursing facilities stay ahead of possible outbreaks. Now, with these live alerts, we can respond hours, if not days faster." Britton-Harr suggests many times the next step from "hotspot" identification is testing, especially for respiratory illnesses. AMS Onsite also provides rapid response testing which recently now includes COVID-19.
Related Industry Updates
Asia Pacific Dry Eye Product Market Report Analysis during 2019-2027 | Novartis, Abbvie, Johnson And Johnson Services Inc., Santen Pharmaceuticals CO. Ltd
Dec 10, 2020
Antinuclear Antibody Test Market To Surge in The Near Future with Rapid Revenue Growth Across Key Industries
Sep 18, 2020
Covid-19 Positive Impact on Europe Organoids Market Research Analysis during 2019-2027 with CAGR growth value 22.5%| Business Market Insights
Apr 06, 2021
United States Retail Clinics Market to Witness an Outstanding Growth During 2020 With Top Key Players Kroger, CVS Health's MinuteClinic, Rite Aid Corp., Doctors Care., NEXtCARE, RediClinic, Target Brands, Inc., Healthworks, Inc., Walgreen Co., and Urgent Care MSO
Dec 04, 2020
CT Scanner Market is expected to reach US$ 9,596.26 million by 2030
Dec 21, 2023
Europe Cancer Vaccines Market 2027 In-Depth Coverage and Various Important Aspects of Covid 19 Outbreak Impact with top keyplayer like AstraZeneca,GlaxoSmithKline plc.,Aduro Biotech Inc,Pfizer Inc.,Sanofi
Apr 26, 2021
GAIA and Daiichi Sankyo Europe Partner to Launch Digital Therapeutics
Mar 10, 2026